BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 12776191)

  • 1. Loss of GFAP expression in high-grade astrocytomas does not contribute to tumor development or progression.
    Wilhelmsson U; Eliasson C; Bjerkvig R; Pekny M
    Oncogene; 2003 May; 22(22):3407-11. PubMed ID: 12776191
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Enhanced glial fibrillary acidic protein-delta expression in human astrocytic tumor.
    Choi KC; Kwak SE; Kim JE; Sheen SH; Kang TC
    Neurosci Lett; 2009 Oct; 463(3):182-7. PubMed ID: 19647039
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of antisense glial fibrillary acidic protein complementary DNA on the growth, invasion, and adhesion of human astrocytoma cells.
    Rutka JT; Hubbard SL; Fukuyama K; Matsuzawa K; Dirks PB; Becker LE
    Cancer Res; 1994 Jun; 54(12):3267-72. PubMed ID: 8205549
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Oligodendrogliomas result from the expression of an activated mutant epidermal growth factor receptor in a RAS transgenic mouse astrocytoma model.
    Ding H; Shannon P; Lau N; Wu X; Roncari L; Baldwin RL; Takebayashi H; Nagy A; Gutmann DH; Guha A
    Cancer Res; 2003 Mar; 63(5):1106-13. PubMed ID: 12615729
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Correlation of glial fibrillary acidic protein (GFAP) with grading of the neuroglial tumours.
    Reyaz N; Tayyab M; Khan SA; Siddique T
    J Coll Physicians Surg Pak; 2005 Aug; 15(8):472-5. PubMed ID: 16202357
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Glial fibrillary acidic protein expression in pleomorphic adenoma, chordoma, and astrocytoma. A comparison of three antibodies.
    Wittchow R; Landas SK
    Arch Pathol Lab Med; 1991 Oct; 115(10):1030-3. PubMed ID: 1654872
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Transformation of astrocytes in transgenic mice expressing SV40 T antigen under the transcriptional control of the glial fibrillary acidic protein promoter.
    Danks RA; Orian JM; Gonzales MF; Tan SS; Alexander B; Mikoshiba K; Kaye AH
    Cancer Res; 1995 Oct; 55(19):4302-10. PubMed ID: 7671240
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A2B5 lineages of human astrocytic tumors and their recurrence.
    Xia CL; Du ZW; Liu ZY; Huang Q; Chan WY
    Int J Oncol; 2003 Aug; 23(2):353-61. PubMed ID: 12851684
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reduced latency but no increased brain tumor penetrance in mice with astrocyte specific expression of a human p53 mutant.
    Klein MA; Rüedi D; Nozaki M; Dell EW; Diserens AC; Seelentag W; Janzer RC; Aguzzi A; Hegi ME
    Oncogene; 2000 Nov; 19(47):5329-37. PubMed ID: 11103934
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transfection of human astrocytoma cells with glial fibrillary acidic protein complementary DNA: analysis of expression, proliferation, and tumorigenicity.
    Rutka JT; Smith SL
    Cancer Res; 1993 Aug; 53(15):3624-31. PubMed ID: 8339269
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Aberrant nestin expression during ethylnitrosourea-(ENU)-induced neurocarcinogenesis.
    Jang T; Litofsky NS; Smith TW; Ross AH; Recht LD
    Neurobiol Dis; 2004 Apr; 15(3):544-52. PubMed ID: 15056462
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression of cathepsin D in human astrocytic neoplasias.
    Warich M; von Bossanyi P; Dietzmann K
    Gen Diagn Pathol; 1995 Oct; 141(2):93-6. PubMed ID: 8548599
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Clinicopathological study on malignant glioma--with special reference to GFAP].
    Tajika T; Kubo O; Tajika Y; Toyama T; Himuro H; Inoue N; Sakairi M; Kitamura K
    No Shinkei Geka; 1986 Jun; 14(7):831-5. PubMed ID: 3020463
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Astrocyte-specific expression of activated p21-ras results in malignant astrocytoma formation in a transgenic mouse model of human gliomas.
    Ding H; Roncari L; Shannon P; Wu X; Lau N; Karaskova J; Gutmann DH; Squire JA; Nagy A; Guha A
    Cancer Res; 2001 May; 61(9):3826-36. PubMed ID: 11325859
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Vimentin and glial fibrillary acidic protein expression in relation to neoplastic cell differentiation in glial tumors.
    Pazanin L; Poljaković Z; Palić J
    Neurol Croat; 1992; 41(4):191-203. PubMed ID: 1463804
    [TBL] [Abstract][Full Text] [Related]  

  • 16. p16(ink4a) and retinoic acid modulate rhoA and GFAP expression during induction of a stellate phenotype in U343 MG-A astrocytoma cells.
    Langlois A; Lee S; Kim DS; Dirks PB; Rutka JT
    Glia; 2002 Oct; 40(1):85-94. PubMed ID: 12237846
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Expression of myelin basic protein and glial fibrillary acidic protein genes in human glial brain tumors].
    Dmytrenko VV; Boĭko OI; Shostak KO; Bilets'kyĭ AV; Malysheva TA; Shamaiev MI; Kliuchka VM; Rozumenko VD; Zozulia IuP; Kavsan VM
    Tsitol Genet; 2009; 43(1):28-35. PubMed ID: 19663312
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An immunocytochemical comparison of the glia-associated proteins glial fibrillary acidic protein (GFAP) and S-100 protein (S100P) in human brain tumors.
    Kimura T; Budka H; Soler-Federsppiel S
    Clin Neuropathol; 1986; 5(1):21-7. PubMed ID: 3512139
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Use of monoclonal antibodies to glial fibrillary acidic protein in the cytologic diagnosis of brain tumors.
    Chen Y; Zhang YX
    Acta Cytol; 1989; 33(6):922-8. PubMed ID: 2588925
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Patterns of expression of TSC-22 protein in astrocytic gliomas.
    Shostak KO; Dmitrenko VV; Vudmaska MI; Naidenov VG; Beletskii AV; Malisheva TA; Semenova VM; Zozulya YP; Demotes-Mainard J; Kavsan VM
    Exp Oncol; 2005 Dec; 27(4):314-8. PubMed ID: 16404353
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.